High-resistance inspiratory muscle strength training, or IMST, can help strengthen your breathing muscles. Practicing it for ...

Despite affecting approximately 1% of the population and carrying significant mortality risk, pulmonary hypertension (PH) remains underrecognized compared to other cardiovascular conditions. Several ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...

Residence at high altitudes (HAs) may increase cardiovascular risk due to hypobaric hypoxia, but its synergy with pulmonary hypertension cause is unclear. This study compared clinical profile and ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries that go from your heart to your lungs. It happens when these arteries become narrow or blocked, making it harder ...

Please provide your email address to receive an email when new articles are posted on . Advancements in treatment directed by risk stratification and the availability of novel targeted therapy provide ...

Pulmonary hypertension (PH) is a complex and progressive disease characterized by elevated pulmonary vascular resistance. Inflammation plays an important role in the pathogenesis of PH. Interferons ...

RAHWAY, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved an update to the U.S.

On October 27, 2025, Absolutaris Base announced the official upgrade of its core product, the CV (Clive Finerton) intelligent system, to version 5.0. This milestone marks a new era for smart financial ...

Pulmonary arterial hypertension (PAH) is a type of high blood pressure in the arteries in your lungs. It happens when these arteries become narrow or blocked, making it harder for blood to flow ...